Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Medicaid and CHIP Sickle Cell Disease Report, T-MSIS Analytic Files (TAF) 2017
source: Centers for Medicare and Medicaid Services
year: 2021
summary/abstract:Sickle cell disease (SCD), the most prevalent lifelong inherited blood disorder in the United States, causes the body to produce red blood cells shaped like crescents or sickles rather than discs. These sickle-shaped blood cells tend to stick to vessel walls leading to blockage and impeding blood flow. When this occurs, oxygen is not delivered to body tissues, which ultimately leads to severe acute and chronic pain episodes known as crises.
SCD impacts all racial and ethnic groups. Of the approximate 100,000 people affected by SCD in the United States, Black and Hispanic populations are disproportionately impacted. While medical advancements, such as newborn screening, penicillin prophylaxis and therapeutics have transitioned SCD from a fatal childhood disease to a chronic condition, long-term health complications (for example, stroke, acute chest syndrome, and chronic end-organ damage) have been associated with increased morbidity and mortality among people with SCD compared to those without.
full text
+myBinderRelated Content
-
Sickle Strong InitiativeThe Sickle Strong Initiative is an organ...
-
James R. Clark Memorial Sickle Cell FoundationThe James R. Clark Memorial Sickle Cell ...
-
Crisis OverCrisis Over is a sickle cell disease blo...
-
A Guide to Living With Sickle Cell Disease: Define Yourself, Define Your LifeDefine yourself, define your life. No ma...
-
Conversation With Women in the Sickle Cell CommunitySickle Cell Project of NW Ohio at Neighb...
-
Today’s Faces of Sickle Cell Disease: Mercy MendozaMercy Mendoza was born in Honduras, and ...
-
Sickle International Family CoalitionThe mission of the Sickle International ...
Don’t forget to join the oneSCDvoice community!
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.